Brain Cancer @ Leeds
We are a consortium of investigators from both basic research and clinical backgrounds, working to understand the processes that promote the development of different brain cancers, and translate our research findings for the benefit of brain cancer patients. Aggressive brain tumours have devastating outcomes for patients and their families. Through understanding their biology and establishing a clear route from laboratory to the clinic, we aim to contribute to more efficacious treatments for these diseases.
Signal Transduction and Tumour Microenvironment Group – lead by Dr Georgia Mavria
For information on the Signal Transduction and Tumour Microenvironment Group see here
Nuclear Receptor Research Group – lead by Dr Laura Matthews
Translational Cancer Immunotherapy Group– lead by Dr Adel Samson